Advanced glycation end products increases matrix metalloproteinase-1, -3, and -13, and TNF-α in human osteoarthritic chondrocytes

被引:147
作者
Nah, Seong-Su
Choi, In-Young
Yoo, Bin
Kim, Yong Gil
Moon, Hee-Bom
Lee, Chang-Keun
机构
[1] Univ Ulsan, Asan Med Ctr, Div Allergy & Rheumatol, Dept Internal Med,Coll Med, Seoul 138736, South Korea
[2] Asan Inst Life Sci, Seoul 138736, South Korea
关键词
advanced glycation end products; matrix metalloproteinase; tumor necrosis factor-alpha; nuclear factor-kappa B; chondrocyte; osteoarthritis;
D O I
10.1016/j.febslet.2007.03.090
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
We investigated the effects of advanced glycation end products (AGE) which accumulate in articular cartilage with age in human osteoarthritic chondrocytes. We found AGE-BSA significantly increased MMP-1, -3, and -13, and TNF-alpha in a dose-dependent manner. AGE-BSA-stimulated JNK, p38, and ERK and NF-kappa B activity. The stimulatory effect of AGE-BSA on MMP-1, -3, and -13 were reversed by treatment with specific JNK, p38 inhibitors, suggesting JNK and p38 are involved in AGE-BSA-induced MMPs and TNF-alpha. We also observed that NF-kappa B is involved in AGE-BSA-induced TNF-alpha. Pretreatment with soluble receptor for AGE (sRAGE) also reduced AGE-stimulated MMPs and TNF-alpha, implicating the involvement of receptor for AGE (RAGE). In conclusion, accumulation of AGE may have a role in the development of osteoarthritis by increasing MMP-1, -3, and -13, and TNF-alpha. (c) 2007 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1928 / 1932
页数:5
相关论文
共 24 条
[1]
Induction of advanced glycation end products and alterations of the tensile properties of articular cartilage [J].
Chen, AC ;
Temple, MM ;
Ng, DM ;
Verzijl, N ;
DeGroot, J ;
TeKoppele, JM ;
Sah, RL .
ARTHRITIS AND RHEUMATISM, 2002, 46 (12) :3212-3217
[2]
Accumulation of advanced glycation end products as a molecular mechanism for aging as a risk factor in osteoarthritis [J].
DeGroot, J ;
Verzijl, N ;
Wenting-van Wijk, MJG ;
Jacobs, KMG ;
Van El, B ;
Van Roermund, PM ;
Bank, RA ;
Bijlsma, JWJ ;
TeKoppele, JM ;
Lafeber, FPJG .
ARTHRITIS AND RHEUMATISM, 2004, 50 (04) :1207-1215
[3]
DeGroot J, 1999, ARTHRITIS RHEUM, V42, P1003, DOI 10.1002/1529-0131(199905)42:5<1003::AID-ANR20>3.0.CO
[4]
2-K
[5]
Accumulation of advanced glycation end products decreases collagen turnover by bovine chondrocytes [J].
DeGroot, J ;
Verzijl, N ;
Budde, M ;
Bijlsma, JWJ ;
Lafeber, FPJG ;
Tekoppele, JM ;
TeKoppele, JM .
EXPERIMENTAL CELL RESEARCH, 2001, 266 (02) :303-310
[6]
Farboud B, 1999, MOL VIS, V5, pU1
[7]
Osteoarthritis: New Insights. Part 1: The Disease and Its Risk Factors [J].
Felson, DT ;
Lawrence, RC ;
Dieppe, PA ;
Hirsch, R ;
Helmick, CG ;
Jordan, JM ;
Kington, RS ;
Lane, NE ;
Nevitt, MC ;
Zhang, YQ ;
Sowers, M ;
McAlindon, T ;
Spector, TD ;
Poole, AR ;
Yanovski, SZ ;
Ateshian, G ;
Sharma, L ;
Buckwalter, JA ;
Brandt, KD ;
Fries, JF .
ANNALS OF INTERNAL MEDICINE, 2000, 133 (08) :635-646
[8]
Transgenic expression of human S100A12 induces structural airway abnormalities and limited lung inflammation in a mouse model of allergic inflammation [J].
Bowman, M. A. Hofmann ;
Heydemann, A. ;
Gawdzik, J. ;
Shilling, R. A. ;
Camoretti-Mercado, B. .
CLINICAL AND EXPERIMENTAL ALLERGY, 2011, 41 (06) :878-889
[9]
Huang JS, 2001, J CELL BIOCHEM, V81, P102, DOI 10.1002/1097-4644(20010401)81:1<102::AID-JCB1027>3.0.CO
[10]
2-Y